Commentary: AARP has a massive conflict of interest in drug price debate

THE ROANOKE TIMES

Read more here.

Previous
Previous

Global freeloading: Americans shouldn’t bear the brunt of drug development costs

Next
Next

The Fight for Freedom in Health, Regulation, and Nutrition: Key Takeaways from CPAC 2025